ENTITY
China Isotope & Radiation Co

China Isotope & Radiation Co (1763 HK)

3
Analysis
Health CareChina
China Isotope & Radiation Corporation develops, manufactures, distributes nuclear products. The Company provides nuclear reactors and cyclotron, radio-pharmaceuticals, radioactive sources, radiation engineering, and other related services. China Isotope & Radiation markets its products cross worldwide.
more
bullishSmartkarma
12 Sep 2019 15:33

Hong Kong IPO Analytics - Regular Cornerstone Investors and Track Record

At the beginning of this year, we at Aequitas Research, wrote on IPO analytics of deals across Asia-Pacific from 2016 to 2018. If you have not read...

Share
bullishSmartkarma
07 Jul 2018 13:57

Smartkarma: ECM Coverage Weekly Update (7 July 2018)

The Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs. Hong Kong IPOs has...

Share
26 Jun 2018 16:07

China Isotope & Radiation IPO: Oligopoly, Visible Growth and High Barrier to Entry

China Isotope & Radiation, the leading radiopharmaceuticals players in China, is raising up to USD 284 million in its listing in Hong Kong. In...

Logo
417 Views
Share
No more insights
x